Lobbying return by Irish Kidney Association
HealthPriority for Vaccination of Renal Patients improved
Politician · TD · 34th Dáil
Check it yourself
Returns filed on the Register of Lobbying, newest first, with the policy area and intended results as the lobbyist published them.
Priority for Vaccination of Renal Patients improved
Recognition of the impact of Covid-19 on Consultants and the need for increased capacity, staffing and funding to improve the delivery of health care in acute hospital and mental health services.
Support sought for commencement of discussions on new scheme to enable access to dental care for medical card patients
Expedition of vaccination of dentists and their teams plus enabling dentists to volunteer as vaccinators
To secure 7 ECLO posts in total across the state
To secure 7 additional ECLO posts
Policy Change and a Joint Committee Meeting
reimbursement for Luxturna
Published name "JKS Communications" has no legal form. "JKS COMMUNICATIONS LIMITED" (CRO 507938) is the only CRO company with that name plus any legal form (Limited, DAC, UC, CLG, PLC or Teoranta). Confirm against the CRO record before relying on it.
To provide public representatives with facts relating to vaping and its benefits to those quitting cigarettes
An extension to current agreement, pending a new agreement to be agreed.
Published name "Irish Pharmaceutical Healthcare Association" equals CRO name "IRISH PHARMACEUTICAL HEALTHCARE ASSOCIATION" (CRO 254776) after normalising legal forms such as Ltd = Limited. No other CRO company has this name. Names can be shared, so compare the address and dates on the CRO record.
Faster access to new medicines
Published name "Irish Pharmaceutical Healthcare Association" equals CRO name "IRISH PHARMACEUTICAL HEALTHCARE ASSOCIATION" (CRO 254776) after normalising legal forms such as Ltd = Limited. No other CRO company has this name. Names can be shared, so compare the address and dates on the CRO record.
Prioritisation of Heart Failure Patients from Level 7 to Level 4
To secure improved access to healthcare for Trans young people.
Asked certain TDs, Senators and Councillor to attend a Fórsa briefing in May on the health sector.
Fighting Blindness hopes to have gene therapy Luxturna made available to those patients with a mutated RPE65 gene that causes sight loss.
Published name "Fighting Blindness" equals CRO name "FIGHTING BLINDNESS" (CRO 109625) after normalising legal forms such as Ltd = Limited. No other CRO company has this name. Names can be shared, so compare the address and dates on the CRO record.